- Home
- TPST vs PIII Comparison
TPST vs PIII Comparison
Compare TPST & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- PIII
- Stock Information
- Founded
- TPST 2011
- PIII 2015
- Country
- TPST United States
- PIII United States
- Employees
- TPST N/A
- PIII N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- TPST Health Care
- PIII Health Care
- Exchange
- TPST Nasdaq
- PIII Nasdaq
- Market Cap
- TPST 27.2M
- PIII 32.2M
- IPO Year
- TPST N/A
- PIII N/A
- Fundamental
- Price
- TPST $0.93
- PIII $0.21
- Analyst Decision
- TPST Strong Buy
- PIII Buy
- Analyst Count
- TPST 4
- PIII 3
- Target Price
- TPST $20.00
- PIII $2.38
- AVG Volume (30 Days)
- TPST 1.8M
- PIII 5.4M
- Earning Date
- TPST 11-12-2024
- PIII 11-12-2024
- Dividend Yield
- TPST N/A
- PIII N/A
- EPS Growth
- TPST N/A
- PIII N/A
- EPS
- TPST N/A
- PIII N/A
- Revenue
- TPST N/A
- PIII $1,476,630,000.00
- Revenue This Year
- TPST N/A
- PIII $21.45
- Revenue Next Year
- TPST N/A
- PIII N/A
- P/E Ratio
- TPST N/A
- PIII N/A
- Revenue Growth
- TPST N/A
- PIII 25.38
- 52 Week Low
- TPST $0.70
- PIII $0.18
- 52 Week High
- TPST $6.00
- PIII $1.35
- Technical
- Relative Strength Index (RSI)
- TPST 54.03
- PIII 43.13
- Support Level
- TPST $0.86
- PIII $0.19
- Resistance Level
- TPST $1.05
- PIII $0.29
- Average True Range (ATR)
- TPST 0.08
- PIII 0.03
- MACD
- TPST 0.01
- PIII 0.00
- Stochastic Oscillator
- TPST 52.92
- PIII 14.29
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.